HG Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HG Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.74M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.51M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $11.11M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $14.48M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.44M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 29, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.25M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $10.92M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $10.53M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $14.07M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.11M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 29, 2022 |
| FY2017 | Dec 31, 2017 | ($2.47M) | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | $2.33M | Mar 23, 2018 |
| FY2017 | Jun 30, 2017 | $2.73M | Mar 23, 2018 |
| FY2017 | Mar 31, 2017 | $2.24M | Mar 23, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($239.0K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($822.0K) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.74M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.76M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $63.0K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $170.0K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($1.44M) | Mar 13, 2020 |
| FY2017 | Dec 31, 2017 | ($7.00M) | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | ($305.0K) | Mar 23, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | ($1.30M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($1.13M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($1.01M) | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | ($823.0K) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($5.57M) | Mar 23, 2018 |
| FY2016 | Dec 31, 2015 | $1.02M | Apr 4, 2017 |
| FY2015 | Dec 31, 2014 | ($2.87M) | Feb 23, 2016 |
| FY2014 | Sep 27, 2014 | ($670.0K) | Feb 25, 2015 |
| FY2014 | Jun 28, 2014 | ($1.46M) | Feb 25, 2015 |
| FY2014 | Mar 29, 2014 | ($1.34M) | Feb 25, 2015 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.58M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $12.99M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $10.24M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.31M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $1.30M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $1.13M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.01M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $823.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $13.98M | Mar 23, 2018 |
| FY2016 | Dec 31, 2015 | $12.66M | Apr 4, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $878.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.96M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.68M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.71M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($935.0K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $290.0K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $1.40M | Mar 1, 2021 |
| FY2016 | Dec 31, 2016 | ($2.59M) | Apr 4, 2017 |
| FY2016 | Dec 31, 2015 | $4.59M | Apr 4, 2017 |
| FY2015 | Dec 31, 2014 | ($11.22M) | Feb 23, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $51.0K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $67.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $13.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.0K | Mar 29, 2022 |
| FY2019 | Dec 31, 2018 | $10.0K | Mar 13, 2020 |
| FY2014 | Dec 31, 2013 | $1.87M | Feb 25, 2015 |
| FY2014 | Dec 31, 2012 | $229.0K | Feb 25, 2015 |
| FY2013 | Dec 31, 2011 | $4.35M | Feb 11, 2014 |
| FY2012 | Dec 31, 2010 | $857.0K | Feb 6, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.69M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $42.17M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $41.90M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $41.10M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $38.87M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $27.03M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $14.33M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $14.09M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $32.57M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $36.52M | Mar 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.13M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $10.36M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $9.48M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.68M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $9.30M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $306.0K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $435.0K | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $443.0K | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $20.09M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $16.54M | Mar 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.69M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $31.96M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $32.44M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $33.32M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $29.56M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $26.72M | Mar 29, 2022 |
| FY2021 | Dec 31, 2019 | $13.64M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $13.64M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $12.49M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $19.98M | Mar 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.49M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.49M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.49M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $6.49M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $4.45M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 29, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.94M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.41M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.89M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.78M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($942.0K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($3.70M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($3.77M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($3.94M) | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | ($2.50M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $5.13M | Mar 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.33M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $12.15M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $10.25M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.46M | Mar 28, 2024 |
| FY2013 | Dec 31, 2013 | $7.22M | Feb 11, 2014 |
| FY2013 | Dec 31, 2012 | $10.93M | Feb 11, 2014 |
| FY2013 | Dec 31, 2011 | $15.70M | Feb 11, 2014 |
| FY2013 | Dec 31, 2010 | $25.53M | Feb 11, 2014 |
| FY2012 | Dec 31, 2009 | $41.83M | Feb 6, 2013 |
| FY2011 | Dec 31, 2008 | $44.01M | Jan 31, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
| FY2017 | Dec 31, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Mar 23, 2018 |
| FY2016 | Dec 31, 2016 | 0 | Apr 4, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
| FY2017 | Dec 31, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Mar 23, 2018 |
| FY2016 | Dec 31, 2016 | 0 | Apr 4, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 2.81M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 2.86M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 2.87M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 2.87M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 2.87M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 14.95M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 14.71M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 14.92M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 14.73M | Mar 23, 2018 |